Furuya-Kanamori Luis, Riley Thomas V, Paterson David L, Foster Niki F, Huber Charlotte A, Hong Stacey, Harris-Brown Tiffany, Robson Jenny, Clements Archie C A
Research School of Population Health, The Australian National University, Canberra, ACT, Australia.
Microbiology & Immunology, School of Pathology & Laboratory Medicine, The University of Western Australia, Nedlands, WA, Australia.
J Clin Microbiol. 2016 Dec 28;55(1):216-225. doi: 10.1128/JCM.01779-16. Print 2017 Jan.
Clostridium difficile infection (CDI) is becoming less exclusively a health care-associated CDI (HA-CDI). The incidence of community-associated CDI (CA-CDI) has increased over the past few decades. It has been postulated that asymptomatic toxigenic C. difficile (TCD)-colonized patients may play a role in the transfer of C. difficile between the hospital setting and the community. Thus, to investigate the relatedness of C. difficile across the hospital and community settings, we compared the characteristics of symptomatic and asymptomatic host patients and the pathogens from these patients in these two settings over a 3-year period. Two studies were simultaneously conducted; the first study enrolled symptomatic CDI patients from two tertiary care hospitals and the community in two Australian states, while the second study enrolled asymptomatic TCD-colonized patients from the same tertiary care hospitals. A total of 324 patients (96 with HA-CDI, 152 with CA-CDI, and 76 colonized with TCD) were enrolled. The predominant C. difficile ribotypes isolated in the hospital setting corresponded with those isolated in the community, as it was found that for 79% of the C. difficile isolates from hospitals, an isolate with a matching ribotype was isolated in the community, suggesting that transmission between these two settings is occurring. The toxigenic C. difficile strains causing symptomatic infection were similar to those causing asymptomatic infection, and patients exposed to antimicrobials prior to admission were more likely to develop a symptomatic infection (odds ratio, 2.94; 95% confidence interval, 1.20 to 7.14). Our findings suggest that the development of CDI symptoms in a setting without establishment of hospital epidemics with binary toxin-producing C. difficile strains may be driven mainly by host susceptibility and exposure to antimicrobials, rather than by C. difficile strain characteristics.
艰难梭菌感染(CDI)不再仅仅是一种与医疗保健相关的CDI(HA-CDI)。在过去几十年中,社区相关性CDI(CA-CDI)的发病率有所增加。据推测,无症状产毒素艰难梭菌(TCD)定植患者可能在医院环境和社区之间的艰难梭菌传播中起作用。因此,为了研究医院和社区环境中艰难梭菌的相关性,我们在3年期间比较了有症状和无症状宿主患者的特征以及这两种环境中这些患者的病原体。同时进行了两项研究;第一项研究招募了来自澳大利亚两个州的两家三级护理医院和社区的有症状CDI患者,而第二项研究招募了来自同一三级护理医院的无症状TCD定植患者。共招募了324名患者(96例HA-CDI患者、152例CA-CDI患者和76例TCD定植患者)。在医院环境中分离出的主要艰难梭菌核糖型与在社区中分离出的核糖型相对应,因为发现79%的医院艰难梭菌分离株在社区中分离出了具有匹配核糖型的分离株,这表明这两种环境之间正在发生传播。导致有症状感染的产毒素艰难梭菌菌株与导致无症状感染的菌株相似,入院前接触过抗菌药物的患者更有可能发生有症状感染(优势比,2.94;95%置信区间,1.20至7.14)。我们的研究结果表明,在没有产二元毒素艰难梭菌菌株医院流行的情况下,CDI症状的出现可能主要由宿主易感性和接触抗菌药物驱动,而不是由艰难梭菌菌株特征驱动。